Biggest News Aggregation in the World
📰 Cm Management News

Cm Management News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Cm Management. Real-time updates on events, politics, business and more.

Cytosorbents Co. (NASDAQ:CTSO) Short Interest Down 5.8% in May

Cytosorbents Co. (NASDAQ:CTSO – Get Free Report) was the recipient of a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 1,460,000 shares, a decrease of 5.8% from the April 30th total of 1,550,000 shares. Based on an average trading volume of 102,400 shares, the […]
United States Cm Management Neuberger Berman Group Sargent Investment Group Cytosorbents Corporation Avenir Corp

Cytosorbents (NASDAQ:CTSO) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a research note issued to investors on Sunday. The firm issued a hold rating on the medical research company’s stock. Several other equities analysts have also issued reports on CTSO. B. Riley reissued a buy rating and set a $3.00 target price on […]
United States Sargent Investment Group Cm Management Cytosorbents Corporation Skylands Capital Cytosorbents Company Profile

Barrick Gold Corp (NYSE:GOLD) Shares Acquired by EverSource Wealth Advisors LLC

EverSource Wealth Advisors LLC increased its stake in shares of Barrick Gold Corp (NYSE:GOLD – Free Report) (TSE:ABX) by 175.6% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 1,794 shares of the gold and copper producer’s stock after acquiring an additional 1,143 shares during the period. […]
United States Randgold Resources York Stock Exchange Securities Inc Barrick Gold Corporation Cm Management

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Short Interest Update

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Free Report) was the target of a significant growth in short interest in May. As of May 15th, there was short interest totalling 191,500 shares, a growth of 441.0% from the April 30th total of 35,400 shares. Based on an average daily trading volume, of 185,700 shares, the days-to-cover […]
Hedge Funds Weigh In On Eledon Pharmaceuticals Armistice Capital Eledon Pharmaceuticals Vanguard Group Inc Eledon Pharmaceuticals Inc Eledon Pharmaceuticals Stock Down

Coherus BioSciences (NASDAQ:CHRS) Given "Buy" Rating at HC Wainwright

HC Wainwright reissued their buy rating on shares of Coherus BioSciences (NASDAQ:CHRS – Free Report) in a research report sent to investors on Friday, Benzinga reports. The brokerage currently has a $12.00 price target on the biotechnology company’s stock. Separately, Truist Financial cut their price target on shares of Coherus BioSciences from $8.00 to $7.00 […]
United States Coherus Biosciences Barclays Plc Vanguard Group Inc Coherus Biosciences Company Profile Rafferty Asset Management

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

DURECT Co. (NASDAQ:DRRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of DURECT Co. (NASDAQ:DRRX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the five analysts that are covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month price […]
Cm Management Ironwood Investment Management Investors Inc Richmond Brothers Inc Get Free Report Marketbeat Ratings

Pieris Pharmaceuticals (NASDAQ:PIRS) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a report released on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Trading Down 0.1 % Shares of PIRS stock opened at $10.48 on Thursday. Pieris Pharmaceuticals has a twelve month low of $10.31 and […]
United States Recherches Internationales Servier Les Laboratoires Servier Cm Management Pieris Pharmaceuticals Inc Pieris Pharmaceuticals Company Profile

Pan American Silver (NYSE:PAAS) PT Raised to $23.00 at Scotiabank

Pan American Silver (NYSE:PAAS – Free Report) (TSE:PAAS) had its price target hoisted by Scotiabank from $20.00 to $23.00 in a research note issued to investors on Thursday morning, Benzinga reports. Scotiabank currently has a sector outperform rating on the basic materials company’s stock. Other equities research analysts have also issued reports about the stock. […]
United States Pan American Silver Company Profile Euro Pacific Asset Management Cm Management Jefferies Financial Group Pan American Silver Corp

StockNews.com Begins Coverage on Pieris Pharmaceuticals (NASDAQ:PIRS)

StockNews.com started coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note issued to investors on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Down 0.1 % NASDAQ PIRS opened at $10.48 on Thursday. The business’s 50-day moving average price is $12.87 and […]
United States Recherches Internationales Servier Les Laboratoires Servier Acadian Asset Management Pieris Pharmaceuticals Inc News Ratings For Pieris Pharmaceuticals Daily

Pieris Pharmaceuticals (NASDAQ:PIRS) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note released on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Price Performance PIRS stock opened at $10.48 on Thursday. The firm has a market cap of $13.83 million, a price-to-earnings ratio of […]
United States Recherches Internationales Servier Les Laboratoires Servier Institutional Trading Of Pieris Pharmaceuticals Pfizer Inc Pieris Pharmaceuticals

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science